Wellness

4 min read
Ulcerative colitis pill shows promising results
A phase 2b trial led by Cedars-Sinai found that icotrokinra, a once-daily oral pill, was more effective than placebo in adults with moderate-to-severe ulcerative colitis.
One article in this category.
1 article

4 min read
A phase 2b trial led by Cedars-Sinai found that icotrokinra, a once-daily oral pill, was more effective than placebo in adults with moderate-to-severe ulcerative colitis.